KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Capital Expenditures (2016 - 2025)

Humana has reported Capital Expenditures over the past 17 years, most recently at $202.0 million for Q4 2025.

  • Quarterly results put Capital Expenditures at $202.0 million for Q4 2025, up 31.17% from a year ago — trailing twelve months through Dec 2025 was $546.0 million (down 5.04% YoY), and the annual figure for FY2025 was $546.0 million, down 5.04%.
  • Capital Expenditures for Q4 2025 was $202.0 million at Humana, up from $135.0 million in the prior quarter.
  • Over the last five years, Capital Expenditures for HUM hit a ceiling of $397.0 million in Q4 2021 and a floor of $95.0 million in Q1 2025.
  • Median Capital Expenditures over the past 5 years was $249.0 million (2023), compared with a mean of $230.2 million.
  • Biggest five-year swings in Capital Expenditures: skyrocketed 51.04% in 2021 and later crashed 56.82% in 2024.
  • Humana's Capital Expenditures stood at $397.0 million in 2021, then plummeted by 30.73% to $275.0 million in 2022, then rose by 2.91% to $283.0 million in 2023, then plummeted by 45.58% to $154.0 million in 2024, then surged by 31.17% to $202.0 million in 2025.
  • The last three reported values for Capital Expenditures were $202.0 million (Q4 2025), $135.0 million (Q3 2025), and $114.0 million (Q2 2025) per Business Quant data.